A pragmatic natriuresis guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting al..
A pragmatic natriuresis-guided diuretic approach in patients with acute heart failure significantly increases 24-hour natriuresis without impacting all-cause mortality or heart failure rehospitalization, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and.
Invizius gets MHRA Approval for H-Guard research pharmatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmatimes.com Daily Mail and Mail on Sunday newspapers.